To ensure that scientific research of immediate concern is shared as rapidly as possible, we fast-track accepted articles from the IJTLD and PHA and publish them as edited preprints prior to publication in a journal.
In this State of the Art, the authors reviewed the literature on thromboembolic adverse events reported after vaccination for COVID-19, and review the benefits and risks of the vaccines approved for use. The findings show that vaccine-induced prothrombotic immune thrombocytopenia are rare adverse events reported mainly in women under 60 years of age. Risk factors for vaccine-induced adverse events should be established so that evidence-based decisions can be made. The preprint is free to read.